SEC Form 4 · accession 0001209191-16-129419
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey M Nugent
Director
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.13 | Jun 21, 2016 | A | 12,450 | A | — | Jun 21, 2026 | Common Stock | 12,450 | 12,450 | D |
| Stock Option (Right to Buy)F2 | $1.13 | Jun 21, 2016 | A | 24,590 | A | — | Jun 21, 2026 | Common Stock | 24,590 | 24,590 | D |
Explanation of responses
- F1Option shares vest on June 21, 2017.
- F2(i) One third of the option shares vests on June 30, 2016, (ii) one third of the option shares vests on September 30, 2016, and (iii) the remaining one third of the option shares vests on December 31, 2016.